<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid syndrome</z:e> is a systemic disorder characterized by arterial and/or <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo>, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, recurrent fetal loss, and presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (<z:chebi fb="21" ids="53713">APA</z:chebi>) </plain></SENT>
<SENT sid="1" pm="."><plain>The importance of <z:chebi fb="21" ids="53713">APA</z:chebi> in Turkish children with <z:mp ids='MP_0005048'>thrombosis</z:mp> is unknown </plain></SENT>
<SENT sid="2" pm="."><plain>This study aimed to evaluate the frequency of <z:chebi fb="21" ids="53713">APA</z:chebi> positivity, associated risk factors other than <z:chebi fb="21" ids="53713">APA</z:chebi>, and outcome in children with <z:chebi fb="21" ids="53713">APA</z:chebi> and <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>The presence of <z:chebi fb="21" ids="53713">APA</z:chebi> was investigated in 138 children presenting for evaluation of <z:mp ids='MP_0005048'>thrombosis</z:mp>; other prothrombotic risk factors were also studied </plain></SENT>
<SENT sid="4" pm="."><plain>The frequency of <z:chebi fb="21" ids="53713">APA</z:chebi> positivity among 138 children was 11.6% (16/138) </plain></SENT>
<SENT sid="5" pm="."><plain>The mean age of these 16 children (10 female, 62.5%) was 9.57 +/- 4.59 years (range, 2.5-18.0 years) </plain></SENT>
<SENT sid="6" pm="."><plain>The mean follow-up period was 31.7 +/- 21.7 months (range, 5-60 months) </plain></SENT>
<SENT sid="7" pm="."><plain>Recurrence was observed during follow-up in two patients (12.5%) </plain></SENT>
<SENT sid="8" pm="."><plain>Ten patients (62.5%) had <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo>, five patients (31.3%) <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo>, and one patient (6.3%) <z:hpo ids='HP_0000979'>purpura</z:hpo> fulminans </plain></SENT>
<SENT sid="9" pm="."><plain>Among the thrombotic children with <z:chebi fb="21" ids="53713">APA</z:chebi>, 11 (68.8%) had more than one prothrombotic risk factor other than circulating <z:chebi fb="21" ids="53713">APA</z:chebi> [five patients (31.3%) had two risk factors, two patients (12.5%) had three, and four patients (25.0%) had four] </plain></SENT>
<SENT sid="10" pm="."><plain>Five patients (31.3%) had no additional risk factors </plain></SENT>
<SENT sid="11" pm="."><plain><z:chebi fb="21" ids="53713">APA</z:chebi> should be tested in <z:hpo ids='HP_0000001'>all</z:hpo> children with <z:mp ids='MP_0005048'>thrombosis</z:mp>, especially those with <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> </plain></SENT>
</text></document>